Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
The highest concentration
Oseltamivir phosphate-treated mice present significantly more inflammatory infiltrate in primary tumors (p=0
LOX regulates EGFR cell surface retention to drive tumour progression
amlexanox prevents OVX-induced bone loss by suppressing osteoclast activity
Trabectedin - CAS# 114899-77-3 pone The highest concentrationTrabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug